US OptionsDetailed Quotes

PRQR250117P7500

Watchlist

0.00
0.000.00%

15min DelayClose Jan 7 09:30 ET

0.00High0.00Low

ProQR Therapeutics Stock Discussion

Jaguar8

Dec 11, 2024 06:05

NEWS

$ProQR Therapeutics (PRQR.US)$
Singapore, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Webuy Global Ltd. (NASDAQ:WBUY) ("Webuy" or the "Company"), a Southeast Asian community e-commerce innovator, is thrilled to announce the launch of its cutting-edge Travel AI, Micky1.0. This tool, available through WhatsApp, helps simplify travel planning and provides personalized support whenever and wherever it is needed.
With just a WhatsApp number, users can interact with Micky1.0 to get immediate answers to the...

Trytosaveabit

Dec 11, 2024 06:02

News

$ProQR Therapeutics (PRQR.US)$ Reuters· 2 mins ago
ProQR Therapeutics Announces $8.1 Million in New Funding From Rett Syndrome Research Trust to Expand Rna Editing Collaboration

Stock_Drift

Nov 5, 2024 16:19

After Hours Ticks. 5:18pm

$Pagaya Technologies (PGY.US)$ $XORTX Therapeutics (XRTX.US)$ $Mercury Systems (MRCY.US)$ $Yunji (YJ.US)$ $My Size (MYSZ.US)$ $ProQR Therapeutics (PRQR.US)$ $loanDepot (LDI.US)$ $Sonder Holdings (SOND.US)$ $Revolve Group (RVLV.US)$ $BiomX (PHGE.US)$ $Qualys (QLYS.US)$
📊⚡️📊

Moonlight was in

Oct 16, 2024 13:51

$ProQR Therapeutics (PRQR.US)$ 300%+ let’s she go

Tarzanman™

Oct 16, 2024 11:01

$ProQR Therapeutics (PRQR.US)$
big offering watchout

Tarzanman™

Oct 16, 2024 09:03

💰💸

Share Your Profit/Loss

Jaguar8

Apr 22, 2024 15:33

$ProQR Therapeutics (PRQR.US)$
NEWS
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will present new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first preclinical data for its AX-0810 pipelin...

JESSE JAMES8832

Jan 19, 2024 06:22

ProQR Therapeutics Highlights New Platform Data From Presentation On Axiomer RNA Editing Technology, Company Says Platform Demonstrates Robust In Vivo Editing Capabilities Reporting Up To 70% Editing

$ProQR Therapeutics (PRQR.US)$

Moomoo AI

Jan 18, 2024 06:57

ProQR Therapeutics' short term liquidity and more cash than debt suggest it can manage its debt safely. Its 38% revenue growth is a positive sign, indicating potential for further strong growth.

Is ProQR Therapeutics (NASDAQ:PRQR) Using Too Much Debt?

No comment yet